The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Gastrointestinal motility disorders in scleroderma
Abstract
After the skin, the gastrointestinal tract is the second most common target of systemic sclerosis. The major clinical manifestations include gastroesophageal reflux, small bowel bacterial overgrowth, malnutrition, and intestinal pseudoobstruction. Treatment is symptomatic and supportive. Gastroesophageal reflux can usually be adequately managed with prokinetic drugs, omeprazole, and judicious use of antireflux surgery. If Barrett's esophagus is present, periodic endoscopic monitoring for development of dysplastic changes or adenocarcinoma is indicated. Bacterial overgrowth usually responds to rotating antibiotics and prokinetic drugs. Malnutrition and intestinal pseudoobstruction remain the major problems and often home total parenteral nutrition is required. Intestinal pseudoobstruction occurs in two phases: an early, neuropathic phase may respond to prokinetic drugs (metoclopramide, cisapride, octreotide, and erythromycin) and dietary modification (low-residue diets, vitamin supplementation). In the late myopathic phase, therapy is usually ineffective. Treatment consists of nutritional support. Careful manometric and radiographic localization of affected segments of stomach and small and large intestines may allow judicious surgical resection or venting procedures to reduce symptoms in this unfortunate group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Pathologic observations in systemic sclerosis (scleroderma)
D'Angelo, W. A., Fries, J. F., Masi., A. T., & Shulman, L. E. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90044-8 · Cited by 1,111
Simplified assessment of segmental colonic transit
Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928
Vantrappen, G., Janssens, J., Hellemans, J., & Ghoos, Y. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108740 · Cited by 815
Improvement of Gastric Emptying in Diabetic Gastroparesis by Erythromycin: Preliminary Studies
Janssens, J., Peeters, T. L., Vantrappen, G., Tack, J., Urbain, J. L., De Roo, M., Muls, E., & Bouillon, R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221502 · Cited by 753
Effect of Octreotide on Intestinal Motility and Bacterial Overgrowth in Scleroderma
Soudah, H. C., Hasler, W. L., & Owyang, C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252102 · Cited by 414
Abnormal intestinal motility in diabetics with the gastroparesis syndrome
CAMILLERI, M., & MALAGELADA, J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01206.x · Cited by 328
Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity
Snape, W. J., Matarazzo, S. A., & Cohen, S. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90835-1 · Cited by 247
The gastrointestinal manifestations of scleroderma: Pathogenesis and management
Cohen, S., Laufer, I., Snape, W. J., Shiau, Y.-F., Levine, G. M., & Jimenez, S. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90091-8 · Cited by 224
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction
Camilleri, M., Malagelada, J.-R., Abell, T. L., Brown, M. L., Hench, V., & Zinsmeister, A. R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90893-7 · Cited by 199
The Pathogenesis of Esophageal Dysfunction in Scleroderma and Raynaud's Disease
Cohen, S., Fisher, R., Lipshutz, W., Turner, R., Myers, A., & Schumacher, R. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107084 · Cited by 195
Chronic Intestinal Pseudo-Obstruction: A REPORT OF 27 CASES AND REVIEW OF THE LITERATURE
SCHUFFLER, M. D., ROHRMANN, C. A., CHAFFEE, R. G., BRAND, D. L., DELANEY, J. H., & YOUNG, J. H. (1981) · Medicine · doi:10.1097/00005792-198105000-00002 · Cited by 188
TALLEY, N. J. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00050.x · Cited by 170
Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.
Tj, P., & Rankin, G. B. (1972) · PubMed · Cited by 169
Esophageal scintigraphy to quantitate esophageal transit (quantitation of esophageal transit)
Tolin, R. D., Malmud, L. S., Reilley, J., & Fisher, R. S. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90408-6 · Cited by 164
Jian, R., Ducrot, F., Piedeloup, C., Mary, J. Y., Najean, Y., & Bernier, J. J. (1985) · Gut · doi:10.1136/gut.26.4.352 · Cited by 151
Greydanus, M. P., & Camilleri, M. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90770-1 · Cited by 146
Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma
Katzka, D. A., Reynolds, J. C., Saul, S. H., Plotkin, A., Lang, C. A., Ouyang, A., Jiménez, S. A., & Cohen, S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90376-7 · Cited by 131
Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis
Horowitz, M., Maddern, G. J., Maddox, A. F., Wishart, J. M., Chatterton, B. E., & Shearman, D. J. C. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91020-1 · Cited by 128
Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability
Dessein, P. H., Joffe, B. I., Metz, R. M., Millar, D. L., Lawson, M., & Stanwix, A. E. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90043-b · Cited by 117
Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis
Maddern, G. J., Horowitz, M., Jamieson, G. G., Chatterton, B. E., Collins, P., & Roberts-Thomson, P. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90089-1 · Cited by 115
Prevalence of Raynaud phenomenon in the general population
Maricq, H. R., Weinrich, M. C., KEIL, J. E., & LeRoy, E. C. (1986) · Journal of Chronic Diseases · doi:10.1016/0021-9681(86)90109-8 · Cited by 111
Malabsorption in Intestinal Scleroderma: Correction by Antibiotics
Kahn, I. J., Jeffries, G. H., & Sleisenger, M. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196606162742402 · Cited by 103
Interdigestive motor activity in patients with systemic sclerosis.
Rees, W. D., Leigh, R. J., Christofides, N. D., Bloom, S. R., & Turnberg, L. A. (1982) · PubMed · Cited by 101
Review article: promotility drugs in the treatment of gastro‐oesophageal reflux disease
Ramirez, B., & Richter, J. E. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00064.x · Cited by 99
Esophageal dysfunction in collagen disease
TURNER, R., Lipshutz, W. H., MILLER, W., Rittenberg, G. M., Schumacher, H. R., & Cohen, S. (1973) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197303000-00002 · Cited by 98
Influence of the interdigestive myoelectric complex on enteric flora in the rat
Scott, L. D., & Cahall, D. L. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90320-1 · Cited by 98
Dietary intake and nutritional status in patients with systemic sclerosis.
Lundberg, A. C., Åkesson, A., & Akesson, B. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.10.1143 · Cited by 95
Interdiestive Motor Activity in Patients with Systemic Sclerosis
Rees, W. D., Leigh, R. J., Christofides, N. D., Bloom, S. R., & Turnberg, L. A. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80192-3 · Cited by 88
Abnormal Colonic Motility in Progressive Systemic Sclerosis
Battle, W. M., SNAPE, W. J., WRIGHT, S., SULLIVAN, M. A., COHEN, S., MEYERS, A., & TUTHILL, R. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-6-749 · Cited by 87
Marlett, J. A., & Code, C. F. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.5.e432 · Cited by 87
Comparative Esophageal and Anorectal Motility in Scleroderma
Hamel-Roy, J., Devroede, G. J., Arhan, P., Tétreault, L., Duranceau, A., & Ménard, H. A. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80124-4 · Cited by 81
Hendel, J. W., Häge, E., Hendel, J. W., & Stentoft, P. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00571.x · Cited by 80
Clinical aspects of systemic sclerosis (scleroderma).
Silver, R. M. (1991) · Annals of the Rheumatic Diseases · doi:10.1136/ard.50.suppl_4.854 · Cited by 76
Bateman, D. N. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614304 · Cited by 71
Smout, A. J. P. M., Bogaard, J. W., Grade, A., et al. (1985) · Gut · doi:10.1136/gut.26.3.246 · Cited by 67
Chronic Intestinal Pseudo-Obstruction: Diagnosis and Treatment
Colemont, L. J., & Camilleri, M. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65304-x · Cited by 63
Hendel, J. W., Svejgaard, E. L., Walsøe, I., Kieffer, M., & Stenderup, A. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809090188 · Cited by 56
Ultrastructure of the esophagus in scleroderma
Russell, M. L., Friesen, D. L., Henderson, R. D., & Hanna, W. M. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250913 · Cited by 56
Kahan, A., Chaussade, S., Gaudric, M., Freitag, B., Amor, B., Menkes, C. J., Strauch, G., Guerre, J., & Couturier, D. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05593.x · Cited by 55
Murphy, J. R., McNally, P. R., Peller, P. J., & Shay, S. S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01300380 · Cited by 48
Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis
Madsen, J. L., & Hendel, L. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01296011 · Cited by 47
Dull, J. S., Raufman, J., Zakai, M. D., STRASHUN, A. M., & Straus, E. W. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90387-s · Cited by 43
Anti-Centromere Antibody and CREST Syndrome in Patients with Primary Biliary Cirrhosis.
Shoji, I., TAKAGI, T., & Kasukawa, R. (1992) · Internal Medicine · doi:10.2169/internalmedicine.31.1348 · Cited by 37
Nutritional Support in Patients with Systemic Scleroderma
Grabowski, G. A., & Grant, J. P. (1989) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607189013002147 · Cited by 33
Surgical Therapy of Diabetic Gastroparesis
Reardon, T. M., Schnell, G. A., Smith, O. J., & Schubert, T. T. (1989) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198904000-00018 · Cited by 28
Åkesson, A., Blom-Bülow, B., Scheja, A., Wollmer, P., Valind, S., & Wollheim, F. A. (1992) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749209099231 · Cited by 15
Cited by
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring
Savarino, E., Bazzica, M., Zentilin, P., Pohl, D., Parodi, A., Cittadini, G., Negrini, S., Indiveri, F., Tutuian, R., Savarino, V., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1359oc · Cited by 269
Clinical and Upper Gastrointestinal Motility Features in Systemic Sclerosis and Related Disorders
Weston, S., Thumshirn, M., Wiste, J., & Camilleri, M. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00334.x · Cited by 186
Gastrointestinal complications: the most frequent internal complications of systemic sclerosis
Forbes, A., & Marie, I. (2009) · Rheumatology · doi:10.1093/rheumatology/ken485 · Cited by 162
Manetti, M., Neumann, E., Milia, A. F., Tarner, I. H., Bechi, P., Matucci‐Cerinic, M., Ibba‐Manneschi, L., & Müller‐Ladner, U. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22940 · Cited by 82
Metadata
- Authors
- Sjogren, R. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 37
- Issue
- 9
- Pages
- 1265-1282
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2013117232
- Cited by
- 381
- References
- 47
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.